Javascript must be enabled to continue!
Genetic Testing Requests on Gamete Donors After Conception; Pre-Test Counseling Considerations for Patients [8O]
View through CrossRef
INTRODUCTION:
To document the requests for genetic testing on gamete donors after conception and outline counseling considerations for patients to be informed about prior to testing.
METHODS:
All requests for additional genetic testing on sperm donors from January 2013 through September 2016 were reviewed and sorted to identify requests received during ongoing pregnancies.
RESULTS:
Fifty-two requests for additional genetic testing on sperm donors were received. Most requests involved carrier screening for conditions for which patients were identified to be carriers. Some requests involved microarray findings in fetuses that required additional donor testing in order to help interpret fetal risks. Donors in our program are frequently available and willing to participate in additional testing but their availability is not guaranteed and testing can take several weeks or months. This can cause patient distress during pregnancy when the donor is unavailable or willing to have testing or if donor testing takes considerable time to accommodate.
CONCLUSION:
Requests for additional testing on gamete donors are frequently received to help define the risks to a fetus. Prior to testing, patients should be counseled about the potential limitations of testing on a donor should testing be warranted. This will aid in their decision-making process prior to performing testing and help to prepare them for the circumstances they could encounter following their own positive test results.
Title: Genetic Testing Requests on Gamete Donors After Conception; Pre-Test Counseling Considerations for Patients [8O]
Description:
INTRODUCTION:
To document the requests for genetic testing on gamete donors after conception and outline counseling considerations for patients to be informed about prior to testing.
METHODS:
All requests for additional genetic testing on sperm donors from January 2013 through September 2016 were reviewed and sorted to identify requests received during ongoing pregnancies.
RESULTS:
Fifty-two requests for additional genetic testing on sperm donors were received.
Most requests involved carrier screening for conditions for which patients were identified to be carriers.
Some requests involved microarray findings in fetuses that required additional donor testing in order to help interpret fetal risks.
Donors in our program are frequently available and willing to participate in additional testing but their availability is not guaranteed and testing can take several weeks or months.
This can cause patient distress during pregnancy when the donor is unavailable or willing to have testing or if donor testing takes considerable time to accommodate.
CONCLUSION:
Requests for additional testing on gamete donors are frequently received to help define the risks to a fetus.
Prior to testing, patients should be counseled about the potential limitations of testing on a donor should testing be warranted.
This will aid in their decision-making process prior to performing testing and help to prepare them for the circumstances they could encounter following their own positive test results.
Related Results
Follow-up of 12,559 Unrelated Donors of Peripheral Blood Stem Cells or Bone Marrow
Follow-up of 12,559 Unrelated Donors of Peripheral Blood Stem Cells or Bone Marrow
Abstract
Abstract 365
Donor follow-up is indicated to detect potential long-term risks for allogeneic stem cell donors. We sent a follow-up questionna...
Infections of Hepatitis B and C and Malaria Plasmodium Falciparum among Blood Donors in Ife East Local Government Area, Ile Ife, Osun State, Nigeria
Infections of Hepatitis B and C and Malaria Plasmodium Falciparum among Blood Donors in Ife East Local Government Area, Ile Ife, Osun State, Nigeria
Endemic regions for malaria are endemic for other infectious diseases that might affect the malaria infection. Infection with
hepatitis B virus (HBV) and hepatitis C virus (HCV) ar...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Gamete donors’ motivation in a Swedish national sample: is there any ambivalence? A descriptive study
Gamete donors’ motivation in a Swedish national sample: is there any ambivalence? A descriptive study
Abstract Objective. To study donors’ motivation and ambivalence before donation of gametes. Design. Cross‐sectional study. Setting. Seven Swedish university hospital clinics. Sampl...
P2-13-09: First Statewide Experience with Telephone Delivery of Cancer Genetic Counseling.
P2-13-09: First Statewide Experience with Telephone Delivery of Cancer Genetic Counseling.
Abstract
Background: National guidelines and multiple professional medical societies recommend genetic counseling as the standard of care for women with a personal a...
To Assess the Effectiveness of Hypertonic Saline Nebulized Suctioning On Airway Clearance Among Patients On Mechanical Ventilator In Selected Hospitals
To Assess the Effectiveness of Hypertonic Saline Nebulized Suctioning On Airway Clearance Among Patients On Mechanical Ventilator In Selected Hospitals
OBJECTIVES- 1) To assess the airway clearance of patients on mechanical ventilator in experimental and control group in selected hospitals. 2) To assess the effectiveness of hypert...
Editorial: Special Issue: Cypriot Journal of Educational Sciences 2022
Editorial: Special Issue: Cypriot Journal of Educational Sciences 2022
Background
Fundamental changes in the world of work are leaving many workers insecure and uncertain about their future. The situation is aggravated by the Covid-19 pandemic,...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

